↓ Skip to main content

Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model

Overview of attention for article published in Molecular Autism, January 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#26 of 720)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
18 news outlets
blogs
3 blogs
twitter
15 X users
patent
1 patent
peer_reviews
1 peer review site
facebook
3 Facebook pages
wikipedia
1 Wikipedia page

Citations

dimensions_citation
134 Dimensions

Readers on

mendeley
175 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model
Published in
Molecular Autism, January 2015
DOI 10.1186/2040-2392-6-1
Pubmed ID
Authors

Jane C Naviaux, Lin Wang, Kefeng Li, A Taylor Bright, William A Alaynick, Kenneth R Williams, Susan B Powell, Robert K Naviaux

Abstract

Are the symptoms of autism caused by a treatable metabolic syndrome that traces to the abnormal persistence of a normal, alternative functional state of mitochondria? A small clinical trial published in 2017 suggests this is possible. Based on a new unifying theory of pathogenesis for autism called the cell danger response (CDR) hypothesis, this study of 10 boys, ages 5-14years, showed that all 5 boys who received antipurinergic therapy (APT) with a single intravenous dose of suramin experienced improvements in all the core symptoms of autism that lasted for 6-8weeks. Language, social interaction, restricted interests, and repetitive movements all improved. None of these improvements were observed in the placebo group. Larger and longer studies are needed to confirm this promising discovery. This review introduces the concept of M2 (anti-inflammatory) and M1 (pro-inflammatory) mitochondria that are polarized along a functional continuum according to cell stress. The pathophysiology of the CDR, the complementary functions of M1 and M2 mitochondria, relevant gene-environment interactions, and the metabolic underpinnings of behavior are discussed as foundation stones for understanding the improvements in ASD behaviors produced by antipurinergic therapy in this small clinical trial.

X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 175 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 <1%
Unknown 174 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 31 18%
Student > Ph. D. Student 28 16%
Student > Bachelor 20 11%
Student > Master 16 9%
Student > Doctoral Student 13 7%
Other 31 18%
Unknown 36 21%
Readers by discipline Count As %
Agricultural and Biological Sciences 33 19%
Biochemistry, Genetics and Molecular Biology 25 14%
Neuroscience 21 12%
Medicine and Dentistry 21 12%
Psychology 8 5%
Other 23 13%
Unknown 44 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 166. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 September 2023.
All research outputs
#245,369
of 25,460,285 outputs
Outputs from Molecular Autism
#26
of 720 outputs
Outputs of similar age
#2,792
of 360,794 outputs
Outputs of similar age from Molecular Autism
#1
of 11 outputs
Altmetric has tracked 25,460,285 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 720 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.2. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,794 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.